REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
8,142,981
Share change
+67,139
Total reported value
$5,942,000
Price per share
$0.73
Number of holders
32
Value change
+$58,482
Number of buys
9
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q1 2015

As of 31 Mar 2015, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,142,981 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, CONDOR CAPITAL MANAGEMENT, BRIDGEWAY CAPITAL MANAGEMENT INC, Northeast Financial Consultants Inc, and AQR CAPITAL MANAGEMENT LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.